Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 24, 2011
Patent Application Number
12092239
Date Filed
November 2, 2006
Patent Primary Examiner
Patent abstract
The invention encompasses a transdermal patch formulation comprising hGH, at least one sugar, one amino acid or polyol, and a buffer, wherein the buffer maintains the pH of the formulation in the range of about 5 to about 9 and the formulation does not contain both glycine and mannitol.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
